This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Odds & FAQ
What are the current odds for Hantavirus vaccine in 2026?
The market prices Yes at only 6%, with No at 95%. Traders currently see this as unlikely - but live odds are a forecast, not a verdict.
What do traders predict for Hantavirus vaccine in 2026?
No strong consensus yet: Yes tops the implied probabilities at just 6%. Watch how the money moves as the event approaches.
When does the Hantavirus vaccine in 2026 market resolve?
Mark 31 Dec 2026 (175 days left): that's when this market is due to resolve, following Polymarket's published criteria once the result is verified.
How much money is trading on Hantavirus vaccine in 2026?
Traders have put $127.6K through this market so far - a solid gauge of how much real money backs these odds.
How can I trade Hantavirus vaccine in 2026 on Polymarket?
You can watch the odds move here in real time and trade the market directly on Polymarket. As always, prediction trading carries real risk.
Similar Markets
220099%YesNo
230081%YesNo
↑3k76%YesNo
↑3.5k60%YesNo
85–9099%YesNo
<801%YesNo
December 3167%YesNo
October 3143%YesNo
